Surface Oncology Inc

NASDAQ:SURF   10:04:08 AM EDT
1.70
-0.04 (-2.02%)
Earnings Announcements

Surface Oncology Inc- Cash Sufficient To Fund Operations Into 2024

Published: 08/03/2022 11:08 GMT
Surface Oncology Inc (SURF) - Cash Sufficient to Fund Operations Into 2024.
Qtrly Net Loss per Share Basic and Diluted$0.46.
As of June 30, 2022, Cash, Cash Equivalents, Marketable Securities Were $156.6 Million.
Q2 Earnings per Share View $-0.46 -- Refinitiv Ibes Data (analyst estimates).
Q2 Earnings per Share View $-0.46 -- Refinitiv Ibes Data (analyst estimates).
Further Company Coverage: .
((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0.1 Million
Adjusted EPS is expected to be -$0.46

Next Quarter Revenue Guidance is expected to be $3.85 Million
Next Quarter EPS Guidance is expected to be -$0.41

More details on our Analysts Page.